Vivoryon Therapeutics N.V.

LSE:0R3M Stock Report

Market Cap: €61.5m

Vivoryon Therapeutics Balance Sheet Health

Financial Health criteria checks 5/6

Vivoryon Therapeutics has a total shareholder equity of €14.0M and total debt of €0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are €17.0M and €3.0M respectively.

Key information

0%

Debt to equity ratio

€0

Debt

Interest coverage ration/a
Cash€15.27m
Equity€13.98m
Total liabilities€3.01m
Total assets€16.99m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 0R3M's short term assets (€16.0M) exceed its short term liabilities (€1.7M).

Long Term Liabilities: 0R3M's short term assets (€16.0M) exceed its long term liabilities (€1.3M).


Debt to Equity History and Analysis

Debt Level: 0R3M is debt free.

Reducing Debt: 0R3M had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 0R3M has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: 0R3M has less than a year of cash runway if free cash flow continues to reduce at historical rates of 19% each year


Discover healthy companies